Drug reference
meclofenamate
Fenamate (Anthranilic acid), NSAID, Nonselective COX inhibitor · Analgesic, Anti-inflammatory, Antipyretic
Fenamate (Anthranilic acid), NSAID, Nonselective COX inhibitorAnalgesic, Anti-inflammatory, Antipyretic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
C
FDA category + note
Mechanism
Meclofenamate is a nonselective COX inhibitor, possessing pharmacological properties typical of NSAIDs.
Indications
Short-term treatment of pain in soft-tissue injuriesDysmenorrheaPainFeverOsteoarthritisRheumatoid arthritisJuvenile arthritisAnkylosing spondylitisAcute gouty arthritisAcute painful shoulder
Dosing
- Adult
- 50–100 mg 4–6 times/day (maximum 400 mg/day). For patients ≥14 years.
Pharmacokinetics
Onset
Peak plasma concentrations (Cp) 0.5–2 h (3–4 h with food)
Half-life
0.8–2.1 h (parent); 0.5–4 h (active metabolite)
Protein binding
99%
Metabolism
Oxidation to 3-OH (~20% activity of parent)
Contraindications
- Not recommended for use in children
- Not recommended for use in pregnant women
Side effects
Common
CNS side effects (>10%)GI side effects (>10%)Rash (>10%)5% elevated liver enzymes
Pregnancy & lactation
Pregnancy
C
Related guidelines
Ask House about meclofenamate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team